“We are relieved by this outcome, but we are not celebrating. From the start, this case was rooted in bad faith and lacking any basis in facts or science. This case never should have reached our nation’s top court in the first place and the Supreme Court made the only reasonable decision by leaving access to medication abortion using mifepristone unchanged.
“Mifepristone is safe, effective and essential. Guttmacher data show that medication abortion accounted for nearly two-thirds of abortions in the formal US health care system in 2023. Mifepristone also plays a key role in helping many people safely self-manage their abortion.”
“Even with this baseless challenge defeated, we must remain vigilant. The anti-abortion movement is ruthlessly pursuing its end goal of banning abortion nationwide. This attempt to restrict mifepristone was just one prong of a larger strategy that has already done so much damage: Two years after Roe was overturned, abortion is banned in 14 states and severely restricted in many more.
“In the face of relentless attacks, policymakers at all levels need to keep pushing forward expansive and protective policies that ensure everyone can access abortion care using the method that best suits their needs.”